Tech Company Financing Transactions
Synereca Pharmaceuticals Funding Round
i2e Enterprise Oklahoma Fund participated in a $600 thousand funding round for Synereca Pharmaceuticals. The round was announced on 8/5/2015.
Transaction Overview
Company Name
Announced On
8/5/2015
Transaction Type
Venture Equity
Amount
$600,000
Round
Undisclosed
Investors
Proceeds Purpose
With the most recent investment, Synereca has now received $2.5 million in funding to support its development of compounds that address the growing problem of bacterial resistance to current antibiotics.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
865 Research Parkway 400
Oklahoma City, OK 73104
USA
Oklahoma City, OK 73104
USA
Phone
Website
Email Address
Overview
Synereca Pharmaceuticals was created to address the growing problem of bacterial resistance to current antibiotics by developing orally active drugs that restore or increase the effectiveness of existing antibiotics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Clayton Duncan
Chief Financial Officer
Kelle Jones
Chief Operating Officer
Richard Gammans
Chief Scientific Officer
Scott Singleton
VP - Operations
Bennett Love
VP - R & D
Stephen Bocckino
Browse more venture capital transactions:
Prev: 8/5/2015: Leanplum venture capital transaction
Next: 8/5/2015: Improvonia venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs